Betoptic review

Betoptic is part of the family of drugs known as beta blockers, and is often prescribed in its generic form, betaxolol ophthalmic. It is most often prescribed to relieve the pressure in the eye, which can be considerably high in patients suffering from glaucoma. In rare cases, individuals without specific diseases might be prescribed Betoptic if they have unordinary high pressure in the eye. It is prescribed in liquid form, with an eye dropper for dispensing the medicinal solution directly into the eye.

In order to eliminate the potential for infection, the patient should never allow the end of the dropper to touch any surface, including their own fingers. The dropper should remain sterile at all times.

Some patients have difficulty dispensing the fluid into the eye and keeping it there. In order to prevent premature drainage from the eye, the patient should apply a gentle but continuous pressure along the edge of the eye near the nose while the liquid is absorbed.

Some patients will not be able to take this medication. The prescribing physician should determine the patient’s overall state of health prior to prescription. Patients with a medical history which includes diabetes, heart disease such as sick sinus syndrome, heart block, hypertension, or congestive heart failure, asthma or another chronic lung disease such as COPD, or an unusually slow heart rate may not be able to tolerate Betoptic. Some patients with any of these diseases may simply require dosage adjustments or may need special testing and careful monitoring while undergoing drug therapy with Betoptic.

The American Food and Drug Administration rated Betoptic as a pregnancy risk category C, which means that there is not evidence to support whether or not Betoptic will cause harm to a developing fetus. It has also not been determined whether or not this medication is excreted through breast milk. Patients who are pregnant, have a high likelihood of becoming pregnant, or are breast feeding should discuss the risks and the benefits with their physician prior to using this medication.

Each drop should be administered with approximately 5 minutes between drops. Patients should not apply more drop than prescribed and should not apply them too closely together. Doing so may result in an overdose. Patients should not use a double dose of this medication in the event of a missed dose. The patient should apply the dose as soon as the missed dose is remembered, unless it is close to the time for the next dose. In this case there is no need to take the missed dose or to alter dosing schedules.

Despite the fact that this medication is administered via drops to the eye, an overdose can be very serious, even fatal. If an overdose is even suspected, the patient should seek medical care at the nearest urgent care facility or emergency room. An overdose of Betoptic may present with symptoms such as wheezing, shortness of breath, respiratory distress, headaches, slow or hampered heart rate, dizziness, or heart attack.

Side effects should be expected in about 40% of patients. Common side effects require no medical treatment but should be reported to the prescribing physician. Nausea, headaches, fainting, fatigue, burning, stinging, low blood pressure, depression, slow heart rate, and irregular heart rate are all considered to be common side effects.

A much smaller percentage of patients may experience severe and life threatening side effects which require immediate medical attention. Symptoms such as shortness of breath, wheezing, asthma attacks, or congestive heart failure (chest pain, anxiety, and shortness of breath) are cause for immediate medical intervention.

Patients should not take any additional medications, over the counter medicines, herbal remedies, or vitamin supplements without first consulting the physician. Beta blockers are known to cause interactions with Betoptic. Other medicines may be reported over time, thus patients should use caution and practice clear communication with the physician.

Betoptic has the following structural formula:

Chemical structure of betoptic

• Molecular formula of betoptic is C18H29NO3
• Chemical IUPAC Name is 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(1-methylethylamino)propan-2-ol
• Molecular weight is 307.428 g/mol
Betoptic available : 0.25% suspension 10ml bottle, 0.25% suspension 15ml bottle, 0.25% suspension 5ml bottle

Generic name: Betaxolol

Brand name(s): Betaxololum, Betaxon, Kerlone

  Your Betoptic review